Compare CBL & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBL | SSII |
|---|---|---|
| Founded | 1978 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 1993 | N/A |
| Metric | CBL | SSII |
|---|---|---|
| Price | $35.74 | $6.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 150.3K | 64.0K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | ★ 5.04% | N/A |
| EPS Growth | ★ 297.30 | N/A |
| EPS | ★ 4.02 | N/A |
| Revenue | ★ $553,643,000.00 | $36,066,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.87 | ★ N/A |
| Revenue Growth | 5.74 | ★ 158.36 |
| 52 Week Low | $21.10 | $3.02 |
| 52 Week High | $35.80 | $22.42 |
| Indicator | CBL | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 76.20 | 43.03 |
| Support Level | $33.22 | $5.82 |
| Resistance Level | $35.80 | $6.78 |
| Average True Range (ATR) | 0.69 | 0.53 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 96.99 | 47.06 |
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.